APA (7th ed.) Citation

D, D., G, G., AR, B., SK, H., DG, E., H, L., . . . SAW, F. (2025). Correction: RON signalling promotes therapeutic resistance in ESR1 mutant breast cancer. British journal of cancer, 133(6), 913. https://doi.org/10.1038/s41416-025-03096-0

Chicago Style (17th ed.) Citation

D, Dustin, et al. "Correction: RON Signalling Promotes Therapeutic Resistance in ESR1 Mutant Breast Cancer." British Journal of Cancer 133, no. 6 (2025): 913. https://doi.org/10.1038/s41416-025-03096-0.

MLA (9th ed.) Citation

D, Dustin, et al. "Correction: RON Signalling Promotes Therapeutic Resistance in ESR1 Mutant Breast Cancer." British Journal of Cancer, vol. 133, no. 6, 2025, p. 913, https://doi.org/10.1038/s41416-025-03096-0.